SCHEMBL18724754

SCHEMBL18724754

CCCC(=O)OCOC(=O)C(O)C[C@@H](Cc1ccc(-c2cccc(Cl)c2)cc1)NC(=O)c1cc(O)n(C)n1

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 9/20 0.59
▸ EMG1 Q92979 2/20 0.59
▸ MME P08473 16/20 0.54
▸ MMEL1 Q495T6 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17011180 1.00 ACE (0.59) ACEEMG1MMEMMEL1
SCHEMBL17011170 0.91 MME (0.58) ACEEMG1MME
SCHEMBL18724854 0.91 MME (0.58) ACEEMG1MME
SCHEMBL17011181 0.89 MME (0.53) ACEEMG1MME
SCHEMBL18724857 0.89 MME (0.53) ACEEMG1MME
SCHEMBL9930506 0.88 MME (0.68) ACEEMG1MME
SCHEMBL17011174 0.88 MME (0.60) ACEEMG1MME
SCHEMBL17011178 0.87 ACE (0.53) ACEEMG1MMEMMEL1
SCHEMBL19190297 0.87 ACE (0.53) ACEEMG1MMEMMEL1
SCHEMBL9930536 0.87 MME (0.70) ACEMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864292-B1 NEPRILYSIN INHIBITORS THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-04-12 — — EP disclosed
Send feedback